Latest Biotechnology, Pharmaceutical and Healthcare News from Seeking Alpha

08:14 EST 23rd November 2017 | BioPortfolio

Here are the most relevant search results for "Seeking Alpha" found in our extensive news archives from over 250 global news sources.

More Information about Seeking Alpha on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Seeking Alpha for you to read. Along with our medical data and news we also list Seeking Alpha Clinical Trials, which are updated daily. BioPortfolio also has a large database of Seeking Alpha Companies for you to search.

Showing News Articles 1–25 of 6,400+ from Seeking Alpha

Thursday 23rd November 2017

An Integrated BioSci Research On MannKind Corporation: How To Unlock Value?

Wednesday 22nd November 2017

United Therapeutics Stock May Bottom Out After Strong Q3 Results

Celsion Delivering Doxorubicin To Cancer Tissues

Protalix Biotherapeutics: An Update On The Fabry Disease Franchise

An Integrated BioSci Research On Gilead Sciences: Promising Dividends And Favorable Valuations

ChemoCentryx Looks Like An Attractive Investment

Kura Oncology: Expecting Continued Appreciation In 2018

Cabozantinib Franchise Will Continue To Transform Exelixis' Fortunes In 2018

Aquinox Pharmaceuticals: Expecting A Rebound In 2018

Dynavax: Now The Fun Begins

Evogene's (EVGN) CEO Ofer Haviv on Q3 2017 Results - Earnings Call Transcript

MediWound: Doubling Sales Even Before Likely FDA Approval

Herbalife: The Upcoming Catalyst Expected To Bring The Company Down

MyoKardia: Buy The Dip

Aspen Pharmacare Holdings (APNHY) Investor Presentation - Slideshow

Novavax's November Jump: The Start Of Something Bigger?

Restasis Buyers Hit Allergan With An Anti-Trust Lawsuit

Novo Nordisk (NVO) Investor Presentation - Slideshow

Initiating Epizyme As A 'Watch Item' Stock

Gilead: Buying New Growth

The Next Billion Dollar Blockbuster: Why Value Investors Should Look At Omeros Corporation (Part 1)

GW Pharmaceuticals: Bull Thesis Strengthened And Further Upside Expected

Your Daily Pharma Scoop: Teva Valuation, DelMar Lead Candidate, Galapagos Commences Trial

3 Things In Biotech You Should Learn Today: November 22, 2017

Selecta Biosciences: SEL-212 Phase 2 Data Not As Good As Hoped, But The Potential Is Still There

Quick Search

News Quicklinks